Henry A. McKinnell Jr.

DEFINITION of 'Henry A. McKinnell Jr.'

A former CEO and chairman of pharmaceutical giant Pfizer. Born in 1943 in Victoria, Canada, McKinnel Jr. began working with Pfizer in 1971 and became chairman and CEO in 2001. He retired in 2006.

BREAKING DOWN 'Henry A. McKinnell Jr.'

McKinnel Jr. led the company to acquire Warner-Lambert in 2000 and Pharmacia in 2003 and helped Pfizer continue in its success and profitability. McKinnell Jr. and Pfizer received many accolades during his tenure, including his being elected chairman emeritus of Pharmaceutical Research and Manufacturers of America (PhRMA) and Pfizer being named one of the world's most admired companies, the world's most generous company and America's second smartest company at the time, after General Electric.



RELATED TERMS
  1. Tony Earley Jr.

    The chairman and CEO of Detroit-based energy company DTE Energy ...
  2. Herbert M. Allison Jr.

    Became the president and CEO of Fannie Mae in 2008. Fannie Mae ...
  3. Leo F. Mullin

    A former CEO and chairman of Delta Airlines. Born in 1943 in ...
  4. Raúl Alarcón Jr.

    Raúl Alarcón Jr. is the president, CEO and chairman of the Spanish ...
  5. Jamie Dimon

    The chairman, CEO and former president of JPMorgan Chase & ...
  6. Chairman

    An executive elected by a company's board of directors that is ...
Related Articles
  1. Investing Basics

    Pfizer CEO: The Story Behind Ian Read (PFE, AZN)

    Learn about the rise of Ian Read, the CEO of Pfizer. Pfizer is one of the most profitable and largest pharmaceutical companies in the world.
  2. Stock Analysis

    3 Reasons Pfizer Stock Could Fall (PFE)

    Pharmaceutical giant Pfizer (NYSE: PFE) has been something of an anomaly over the past couple of years. Despite facing an unprecedented number of patent cliff issues, its stock has risen by ...
  3. Stock Analysis

    Is Pfizer's Dividend Built to Last? (PFE)

    Pfizer (NYSE: PFE) is the prototypical Big Pharma giant. Among megacap pharmaceutical names, Pfizer generates more revenue from the sale of pharmaceutical products than any other company. During ...
  4. Stock Analysis

    3 Moves Pfizer Should Make for Its Shareholders (PFE, JAZZ)

    PFE data by YCharts. Big pharmaceutical giant Pfizer (NYSE: PFE) isn't often thought of as a substantial growth driver of income investors' portfolios, but over the trailing five-year period, ...
  5. Stock Analysis

    3 Reasons Pfizer Stock Could Rise (PFE)

    Pfizer (NYSE: PFE) is truly facing a challenge of unprecedented magnitude at the moment. While patent issues are something pharmaceutical companies have struggled with from time to time throughout ...
  6. Stock Analysis

    5 Things Pfizer's Management Wants You to Know (PFE)

    It's been just shy of three weeks since pharmaceutical juggernaut Pfizer (NYSE: PFE) reported its first-quarter earnings results, but the overall consensus, based on the headline figures, is ...
  7. Stock Analysis

    Pfizer's 3 Most Important Numbers (PFE)

    Pfizer (NYSE: PFE) is one of the largest and most profitable pharmaceutical companies in the world. Last year alone, it generated $15.3 billion in free cash flow on the heels of a gross margin ...
  8. Stock Analysis

    After A Big Rally, Pfizer Might Need Some Rest

    A big rally has brought Pfizer back to fair value.
  9. Active Trading Fundamentals

    Pfizer's 3 Key Financial Ratios (PFE)

    Learn about three important financial ratios that help understand Pfizer, Inc. business and analyze the company's financial statements.
  10. Stock Analysis

    Pfizer Earnings Preview: 5 Things You Need to Know (PFE, HSP)

    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but it nonetheless remains a critical gauge of success in the pharmaceutical ...
RELATED FAQS
  1. What are some popular mutual funds that give exposure to the drugs sector?

    Discover some of the most widely traded and top-rated mutual funds that investors can use to make profits from gains in the ... Read Answer >>
  2. What is the average price-to-book ratio for companies in the drugs sector?

    Find out more about the price-to-book ratio and what the average P/B ratio is for companies in the drug manufacturers - major ... Read Answer >>
  3. What level of dividend yield can be expected from companies in the drugs sector?

    Find out more about dividend yield, what the dividend yield of a company indicates and the average dividend yields of companies ... Read Answer >>
  4. What countries comprise the majority of the global drugs sector?

    Find out which countries are the largest producers of pharmaceutical products in the world and why the United States dominates ... Read Answer >>
  5. What stock factors should you consider when a company makes a CEO change?

    Learn about factors affecting the price of stock following a change in CEO. Explore why a change in CEO may be positive or ... Read Answer >>
  6. What metrics are often used to evaluate companies in the drugs sector?

    Learn about some of the equity evaluation metrics that are most frequently used for examining companies in the pharmaceutical ... Read Answer >>
Hot Definitions
  1. MACD Technical Indicator

    Moving Average Convergence Divergence (or MACD) is a trend-following momentum indicator that shows the relationship between ...
  2. Over-The-Counter - OTC

    Over-The-Counter (or OTC) is a security traded in some context other than on a formal exchange such as the NYSE, TSX, AMEX, ...
  3. Quarter - Q1, Q2, Q3, Q4

    A three-month period on a financial calendar that acts as a basis for the reporting of earnings and the paying of dividends.
  4. Weighted Average Cost Of Capital - WACC

    Weighted average cost of capital (WACC) is a calculation of a firm's cost of capital in which each category of capital is ...
  5. Basis Point (BPS)

    A unit that is equal to 1/100th of 1%, and is used to denote the change in a financial instrument. The basis point is commonly ...
  6. Sharing Economy

    An economic model in which individuals are able to borrow or rent assets owned by someone else.
Trading Center